FDA OK's Silvergate's Epaned; new ped hypertension option

The US FDA has granted Silvergate Pharmaceuticals approval to market Epaned (enalapril maleate) powder for oral solution to treat high blood pressure for patients as young as one month – providing not only a new option for adults who may have difficulty swallowing pills, but also for babies and children with pediatric hypertension.

More from Alimentary/Metabolic

More from Therapy Areas